These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23213975)

  • 1. Communication in crisis situations in the process of immunization.
    Ravlija J; Vasilj I
    Coll Antropol; 2012 Sep; 36(3):1069-73. PubMed ID: 23213975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The contribution of social medicine to vaccination in Austria].
    Kunze M
    Wien Med Wochenschr; 1998; 148(8-9):191-7. PubMed ID: 9677675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public communication, risk perception, and the viability of preventive vaccination against communicable diseases.
    May T
    Bioethics; 2005 Aug; 19(4):407-21. PubMed ID: 16222856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicians' opinions on new vaccination programs implementation.
    Dubé E; Gilca V; Sauvageau C; Bettinger JA; Boucher FD; McNeil S; Gemmill I; Lavoie F; Ouakki M; Boulianne N
    Vaccine; 2012 Jun; 30(31):4632-7. PubMed ID: 22580354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Media and public reactions toward vaccination during the 'hepatitis B vaccine crisis' in China.
    Chen B; Zhang JM; Jiang Z; Shao J; Jiang T; Wang Z; Liu K; Tang S; Gu H; Jiang J
    Vaccine; 2015 Apr; 33(15):1780-5. PubMed ID: 25731787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding reliable information about vaccines.
    Pineda D; Myers MG
    Pediatrics; 2011 May; 127 Suppl 1():S134-7. PubMed ID: 21502244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Achievements and challenges of the expanded immunization program in the Americas].
    Valenzuela MT; O'Ryan M
    Rev Med Chil; 2000 Aug; 128(8):911-22. PubMed ID: 11129554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities and challenges of Web 2.0 for vaccination decisions.
    Betsch C; Brewer NT; Brocard P; Davies P; Gaissmaier W; Haase N; Leask J; Renkewitz F; Renner B; Reyna VF; Rossmann C; Sachse K; Schachinger A; Siegrist M; Stryk M
    Vaccine; 2012 May; 30(25):3727-33. PubMed ID: 22365840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basis for vaccine recommendations].
    Lévy-Bruhl D
    Med Sci (Paris); 2007 Apr; 23(4):404-8. PubMed ID: 17433231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic research on vaccinations and immunisation practices--an introductory primer.
    Szucs TD
    Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global routine vaccination coverage, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1520-2. PubMed ID: 22071590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The precautionary principle: advantages and risks].
    Tubiana M
    J Chir (Paris); 2001 Apr; 138(2):68-80. PubMed ID: 11319454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why some messages speak better: child immunization in the news and on the internet.
    Rundblad G
    Curr Drug Saf; 2015; 10(1):87-93. PubMed ID: 25859681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communicating vaccine safety to the media and general public.
    Oubari H; Tuttle R; Rath B; Bravo L
    Curr Drug Saf; 2015; 10(1):80-6. PubMed ID: 25859680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines as tools for advancing more than public health: perspectives of a former director of the National Vaccine Program office.
    Breiman RF
    Clin Infect Dis; 2001 Jan; 32(2):283-8. PubMed ID: 11170919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
    Murray J; McFarland DA; Waldman RJ
    Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.